IP Library Granted Patent US 7,087,591
Granted Patent B2
US 7,087,591 · App. 11/065,632 · Granted Aug 8, 2006

21-substituted progesterone derivatives as new antiprogestational agents

Assignee: The United States of America as represented by the Department of Health and Human Services
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,087,591
App. No.
11/065,632
Granted
Aug 8, 2006
Kind
B2
Abstract

A compound having the general formula: in which: R 1 is a member selected from the group consisting of —OCH 3 , —SCH 3 , —N(CH 3 ) 2 , —NHCH 3 , —CHO, —COCH 3 and —CHOHCH 3 ; R 2 is a member selected from the group consisting of halogen, alkyl, acyl, hydroxy, alkoxy, acyloxy, alkyl carbonate, cypionyloxy, S-alkyl and S-acyl; R 3 is a member selected from the group consisting of alkyl, hydroxy, alkoxy and acyloxy; R 4 is a member selected from the group consisting of hydrogen and alkyl; and X is a member selected from the group consisting of ═O and ═N—OR 5 , wherein R 5 is a member selected from the group consisting of hydrogen and alkyl. In addition to providing the compounds of Formula I, the present invention provides methods wherein the compounds of Formula I are advantageously used, inter alia, to antagonize endogenous progesterone; to induce menses; to treat endometriosis; to treat dysmenorrhea; to treat endocrine hormone-dependent tumors; to treat uterine fibroids; to inhibit uterine endometrial proliferation; to induce labor; and for contraception.

Claims (53)

1. A compound having the formula

in which:

R 1 is a member selected from the group consisting of —OCH 3 , —SCH 3 , —N(CH 3 ) 2 , —NHCH 3 , —CHO, —COCH 3 and —CHOHCH 3 ;

R 2 is a member selected from the group consisting of halogen, alkyl, acyl, hydroxy, alkoxy, acyloxy, alkylcarbonate, cypionyloxy, S-alkyl and S-acyl;

R 3 is a member selected from the group consisting of alkyl, hydroxy, alkoxy and acyloxy;

R 4 is a member selected from the group consisting of hydrogen and alkyl; and

X is a member selected from the group consisting of ═O and ═N—OR 5 , wherein R 5 is a member selected from the group consisting of hydrogen and alkyl.

2. A compound in accordance with claim 1 in which:

R 1 is —N(CH 3 ) 2 .

3. A compound in accordance with claim 1 in which:

R 2 is halogen.

4. A compound in accordance with claim 1 in which:

R 2 is alkoxy.

5. A compound in accordance with claim 1 in which:

R 3 is acyloxy.

6. A compound in accordance with claim 1 in which:

R 4 is alkyl.

7. A compound in accordance with claim 1 in which:

X is ═O.

8. A compound in accordance with claim 1 in which:

X is ═N—OR 5 .

9. A compound in accordance with claim 1 in which:

R 1 is —N(CH 3 ) 2 ;

R 2 is halogen;

R 3 is acyloxy;

R 4 is alkyl; and

X is ═O.

10. A compound in accordance with claim 9 in which:

R 2 is F.

11. A compound in accordance with claim 9 in which:

R 2 is Br.

12. A compound in accordance with claim 9 in which:

R 2 is Cl.

13. A compound in accordance with claim 9 in which:

R 4 is methyl.

14. A compound in accordance with claim 1 in which:

R 1 is —N(CH 3 ) 2 ;

R 2 is alkyl;

R 3 is acyloxy;

R 4 is alkyl; and

X is ═O.

15. A compound in accordance with claim 1 in which:

R 1 is —N(CH 3 ) 2 ;

R 2 is alkoxy;

R 3 is acyloxy;

R 4 is alkyl; and

X is ═O.

16. A compound in accordance with claim 15 in which:

R 2 is methoxy.

17. A compound in accordance with claim 15 in which:

R 2 is ethoxy.

18. A compound in accordance with claim 15 in which:

R 3 is acetoxy.

Assignments (2)
LICENSE Recorded Mar 5, 2026
From: TEXAS BIOMEDICAL RESEARCH INSTITUTE
To: NATIONAL INSTITUTES OF HEALTH
Reel/Frame 075020/0027 →
CONFIRMATORY LICENSE Recorded Feb 13, 2024
From: TEXAS BIOMEDICAL RESEARCH INSTITUTE
To: NATIONAL INSTITUTES OF HEALTH
Reel/Frame 066454/0768 →
Continuity (3)
Division 0918013200
Provisional Application 6001662800 · May 1, 1996
Related Publication 20050143364A1 · Jun 30, 2005